Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02716168
Other study ID # Partnership-Project
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date August 2020

Study information

Verified date October 2020
Source University of Southern Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background International guidelines underline the importance of strengthening the coordination and continuity of cancer care. The different roles of general practitioners and oncologists with regard to treatment, follow-up and rehabilitation during and after cancer treatment are often obscure to cancer patients. Parallel courses of healthcare are often taking place instead of coordinated care characterized by continuity and partnership between care providers. Patients may feel uncertain about the health professionals' skills and area of responsibility. Healthcare seeking and support during and after cancer treatment may, therefore, be inappropriate, leaving patients feeling insecure and lost between care providers.The study aims to design and evaluate a new way of communication and shared decision-making that brings the patient, the oncologist and general practitioner together in a shared video-consultation in the early phase of chemotherapeutic treatment. The effect of the intervention in addition to usual care will be tested in a randomized controlled trial at Vejle Hospital in the Region of Southern Denmark. Based on sample size calculation, investigators intent to include 300 patients at the Department of Oncology and their general practitioners. Results and process outcomes will be evaluated qualitatively and quantitatively, questionnaires to patients, general practitioners and oncologists, and data from registers.


Recruitment information / eligibility

Status Completed
Enrollment 281
Est. completion date August 2020
Est. primary completion date August 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Newly referred cancer patient scheduled for chemotherapy at the Department for Oncology, Vejle Hospital, Region of Southern Denmark - Aged 18 years and over - Able to speak and read Danish - Mentally able to cooperate - Listed with a general practitioner (98 % of the danish population) - Written and verbal informed consent given Exclusion Criteria: - none

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Shared video consultation between patient, general practitioner and oncologist
At the start of the patients chemotherapy treatment a shared video consultation between the patient, general practitioner and oncologist will bee arranged. The video consultation should address distribution of roles, comorbidity, medicine, depression and anxiety symptoms, relatives and social resources.

Locations

Country Name City State
Denmark Department of Oncology, Vejle Hospital, Region of Southern Denmark Vejle

Sponsors (6)

Lead Sponsor Collaborator
University of Southern Denmark National Research Center of Cancer Rehabilitation, Odense Patient Data Explorative Network, Region of Southern Denmark, Research Unit of General Practice, Odense, Vejle Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Shared Care questionnaire Patient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist. 7 month after inclusion
Secondary Illness Intrusiveness Rating Scale (IIRS) Patient reported outcome measure. Patients assessment of the cancer disease influence on their daily living. 4 and 7 month after inclusion
Secondary European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire - Core 30 (EORTC QLQ C30) Patient reported outcome measure. Cancer patients assessment of their quality of life 4 and 7 month after inclusion
Secondary European Organisation for Research and Treatment of Cancer - Quality of Life- information questionnaire (EORTC QLQ INFO25) 4 and 7 month after inclusion
Secondary Generalised Anxiety Disorder Assessment (GAD-7) Patient reported outcome measure. Screening tool and severity measure for generalised anxiety disorder 4 and 7 month after inclusion
Secondary Patient Health Questionnaire (PHQ-9) Patient reported outcome measure.The questionnaire monitor the severity of depression and response to treatment. 4 and 7 month after inclusion
Secondary Oncologist assessment of a video consultation between the patient, General practitioner and oncologist. It measures the oncologist perception of the benefits with the video consultation intervention. Only the intervention group Directly after the video consultation intervention
Secondary General practitioners assessment of a video consultation between the patient, General practitioner and oncologist. It measures the General Practitioners perception of the benefits with the video consultation intervention. Only the intervention group. Directly after the video consultation intervention
Secondary Patients assessment of a video consultation between the patient, General practitioner and oncologist. It measures the patients perception of the benefits with the video consultation intervention.Only the intervention group Directly after the video consultation intervention
Secondary General Practitioner cancer trajectory assessment The General Practitioners assessment of the cooperation between the primary and secondary care regarding af specific cancer patient. 4 month after the inclusion of the patient.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links